Covalon Technologies Ltd. Stock

Equities

COV

CA22282D3022

Biotechnology & Medical Research

Market Closed - Toronto S.E. 02:45:41 2024-04-23 pm EDT 5-day change 1st Jan Change
1.1 CAD +0.92% Intraday chart for Covalon Technologies Ltd. 0.00% +3.77%
Sales 2022 18.15M 13.28M Sales 2023 26.6M 19.46M Capitalization 37M 27.07M
Net income 2022 -9M -6.58M Net income 2023 -4M -2.93M EV / Sales 2022 2.65 x
Net cash position 2022 13.26M 9.7M Net cash position 2023 7.23M 5.29M EV / Sales 2023 1.12 x
P/E ratio 2022
-6.44 x
P/E ratio 2023
-8.33 x
Employees 37
Yield 2022 *
-
Yield 2023
-
Free-Float 47.53%
More Fundamentals * Assessed data
Dynamic Chart
Transcript : Covalon Technologies Ltd. - Shareholder/Analyst Call
Covalon Technologies Ltd. Reports Earnings Results for the First Quarter Ended December 31, 2023 CI
Covalon Technologies Reports Management Changes; Narrows Fiscal Q4 Loss, Revenue Grows; Up 17.8% MT
Covalon Technologies Reports Management Changes; Narrows Fiscal Q4 Loss, Revenue Grows MT
Covalon Technologies Narrows Fiscal Q4 Loss, Revenue Grows MT
Covalon Technologies Ltd. Announces Interim Chief Financial Officer Changes CI
Covalon Technologies Ltd. Announces Appointment of Kim Crooks as Senior Vice President - Operations CI
Covalon Technologies Brief: Reporting 2023-Q4 revenue of $6.9 million, an increase of 28%, and net loss from continuing operations of $2.9 million, an improvement of $1.2 million MT
Covalon Technologies Ltd. Reports Earnings Results for the Full Year Ended September 30, 2023 CI
Covalon Technologies Ltd. Reports Earnings Results for the Fourth Quarter Ended September 30, 2023 CI
Covalon Technologies Ltd. Announces Chief Executive Officer Changes CI
Covalon Technologies Ltd. Announces Executive Changes CI
Covalon Technologies Appoints MedTech Executive Brent Ashton as its New Chief Executive MT
Covalon Technologies Brief: Appointing "Experienced" MedTech Executive Brent Ashton as New CEO MT
Covalon Technologies Ltd. to Showcase Innovative Solutions at the Prestigious ANCC National Magnet Conference in Chicago CI
More news

Latest transcript on Covalon Technologies Ltd.

1 day+0.92%
Current month-8.33%
1 month-14.06%
3 months+8.91%
6 months-23.61%
Current year+3.77%
More quotes
1 week
1.08
Extreme 1.08
1.20
1 month
1.08
Extreme 1.08
1.30
Current year
1.00
Extreme 1
1.45
1 year
0.96
Extreme 0.96
2.14
3 years
0.96
Extreme 0.96
3.15
5 years
0.70
Extreme 0.7
5.54
10 years
0.57
Extreme 0.57
9.45
More quotes
Managers TitleAgeSince
Founder - 04-04-27
Chairman - 20-04-26
Chief Operating Officer - 07-12-31
Members of the board TitleAgeSince
Director/Board Member 73 19-03-17
Director/Board Member - 08-03-06
Director/Board Member - 20-04-22
More insiders
Date Price Change Volume
24-04-23 1.1 +0.92% 300
24-04-22 1.09 0.00% 900
24-04-19 1.09 -9.17% 19,500
24-04-18 1.2 +9.09% 10,755
24-04-17 1.1 0.00% 3,100

Delayed Quote Toronto S.E., April 23, 2024 at 02:45 pm EDT

More quotes
Covalon Technologies Ltd. is a patient-driven medical device company. Through a portfolio of patented technologies and solutions for advanced wound care, infection prevention, and medical device coatings, the Company offers gentler and more compassionate options for patients to heal with less infections, less pain, and better outcomes. Its solutions are designed for patients and made for care providers. It leverages its patented medical technology platforms and expertise in two ways: by developing products that are sold under Covalon’s name and by developing and commercializing medical products for other medical companies under development and license contracts. It provides a range of specialized medical devices, medical dressings and advanced medical technology designed for infection prevention, complex wound closure and perioperative care. Its perioperative care solutions provide antimicrobial protection of pre-operative skin, through postoperative incision care to scar prophylaxis.
More about the company